ConductScience.org, home

Paper7044591

VP16-213 and podophyllotoxin. A study on the relationship between chemical structure and biological activity.

Loike JD. Cancer Chemother Pharmacol, 1982. Cited by 37 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. VP16-213 and podophyllotoxin. A study on the relationship between chemical structure and biological activity. Papers, record 7044591. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7044591

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
VP16-213 and podophyllotoxin. A study on the relationship between chemical structure and biological activity.
PubMed
Journal
Cancer Chemother Pharmacol
PubMed
Year
1982
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S., Review
PubMed
Citations, by iCite
37
iCite
Relative citation ratio, by iCite
1.46
iCite
Revised in PubMed
2019-08-30
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Loike JDJ D

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
EtoposideMajor topic
PodophyllotoxinMajor topic
Animals
Chemical Phenomena
Chemistry
DNA
HeLa Cells
Humans
Microtubules
Molecular Conformation
Nucleosides
Structure-Activity Relationship
Teniposide

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CA-15714NCI NIH HHSUnited StatesR01CA015714PubMed and NIH

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17,236,603Kinetic and steady-state analysis of microtubules in the presence of colchicine.Biochemistry1981https://conductscience.org/library/papers/7236603PubMed
2679,171Structure-activity study of the inhibition of microtubule assembly in vitro by podophyllotoxin and its congeners.Cancer Res1978https://conductscience.org/library/papers/679171PubMed
34,374,234Transport of nucleosides, nucleic acid bases, choline and glucose by animal cells in culture.Biochim Biophys Acta1974https://conductscience.org/library/papers/4374234PubMed
4389,478Podophyllotoxin derivative VP 16-213.Cancer Chemother Pharmacol1979https://conductscience.org/library/papers/389478PubMed
5620,419Opposite end assembly and disassembly of microtubules at steady state in vitro.Cell1978https://conductscience.org/library/papers/620419PubMed
6999,819Effect of VP-16-213 on the intracellular degradation of DNA in HeLa cells.Biochemistry1976https://conductscience.org/library/papers/999819PubMed
74,814,747Structure of the mitotic spindle inhibitor colcemid. N-desacetyl-N-methylcolchicine.J Am Chem Soc1974https://conductscience.org/library/papers/4814747PubMed
81,204,664Comparison of the human pharmacokinetics of VM-26 and VP-16, two antineoplastic epipodophyllotixin glucopyranoside derivatives.Eur J Cancer (1965)1975https://conductscience.org/library/papers/1204664PubMed
9348,319VP-16-213 monotherapy for remission induction of small cell lung cancer: a randomized trial using three dosage schedules.Cancer Treat Rep1978https://conductscience.org/library/papers/348319PubMed
105,704,182The effect of podophyllin cytostatics SP-I and SP-G on the proliferation and respiration of HeLa cells in vitro.Neoplasma1968https://conductscience.org/library/papers/5704182PubMed
117,380,913Analysis of the anticancer drugs VP 16-213 and VM 26 and their metabolites by high-performance liquid chromatography.J Chromatogr1980https://conductscience.org/library/papers/7380913PubMed
124,991,9324'-Demethyl-epipodophyllotoxin thenylidene glucoside (VM 26), a podophyllum compound with a new mechanism of action.Eur J Cancer (1965)1970https://conductscience.org/library/papers/4991932PubMed
14385,138Etoposide (VP-16-213).Cancer Treat Rev1979https://conductscience.org/library/papers/385138PubMed
154,760,528Effects of a new antitumor agent, epipodophyllotoxin, on growth and chromosomes in human hematopoietic cell lines.Cancer Res1973https://conductscience.org/library/papers/4760528PubMed
164,626,639Microtubule formation in vitro in solutions containing low calcium concentrations.Science1972https://conductscience.org/library/papers/4626639PubMed
176,058,222Cell motility by labile association of molecules. The nature of mitotic spindle fibers and their role in chromosome movement.J Gen Physiol1967https://conductscience.org/library/papers/6058222PubMed
18489,611Colchicine inhibition of microtubule assembly via copolymer formation.J Biol Chem1979https://conductscience.org/library/papers/489611PubMed
194,787,856Activity of a new glycosidic lignan derivative (VP 16-213) related to podophyllotoxin in experimental tumors.Eur J Cancer (1965)1973https://conductscience.org/library/papers/4787856PubMed
207,240,159Incorporation of radioactive tubulin into microtubules at steady state. Experimental and theoretical analysis of the effect of podophyllotoxin.J Biol Chem1981https://conductscience.org/library/papers/7240159PubMed
22999,818Effects of podophyllotoxin and VP-16-213 on microtubule assembly in vitro and nucleoside transport in HeLa cells.Biochemistry1976https://conductscience.org/library/papers/999818PubMed

See all 41 references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.

PMIDTitleJournalYearIn PapersSource
31,614,754Broken by the Cut: A Journey into the Role of Topoisomerase II in DNA Fragility.Genes (Basel)2019https://conductscience.org/library/papers/31614754PubMed
31,106,192Synthesis and Biological Evaluation of 4β-N-Acetylamino Substituted Podophyllotoxin Derivatives as Novel Anticancer Agents.Front Chem2019https://conductscience.org/library/papers/31106192PubMed
28,884,079Podophyllotoxin: a novel potential natural anticancer agent.Avicenna J Phytomed2017https://conductscience.org/library/papers/28884079PubMed
18,355,043Substituents on etoposide that interact with human topoisomerase IIalpha in the binary enzyme-drug complex: contributions to etoposide binding and activity.Biochemistry2008https://conductscience.org/library/papers/18355043PubMed
17,580,961Topoisomerase II - drug interaction domains: identification of substituents on etoposide that interact with the enzyme.Biochemistry2007https://conductscience.org/library/papers/17580961PubMed
15,139,794Pharmacokinetic optimisation of treatment with oral etoposide.Clin Pharmacokinet2004https://conductscience.org/library/papers/15139794PubMed
8,324,871Cytotoxic properties of a new synthetic demethylpodophyllotoxin derivative, BN 58705, against human tumor cell lines.Cancer Chemother Pharmacol1993https://conductscience.org/library/papers/8324871PubMed
6,861,265Flow-cytometric analysis of DNA distribution after VP16-213 treatment of Lewis lung carcinoma.Cancer Chemother Pharmacol1983https://conductscience.org/library/papers/6861265PubMed
6,488,441Pharmacokinetic study of VM26 given as a prolonged IV infusion to ovarian cancer patients.Cancer Chemother Pharmacol1984https://conductscience.org/library/papers/6488441PubMed
3,297,462The clinical pharmacology of etoposide and teniposide.Clin Pharmacokinet1987https://conductscience.org/library/papers/3297462PubMed
3,047,665Etoposide and teniposide. Bioanalysis, metabolism and clinical pharmacokinetics.Pharm Weekbl Sci1988https://conductscience.org/library/papers/3047665PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7044591

GET https://conductscience.org/api/papers/v1/7044591/references?page=2